Latest News

Remdesivir prevents COVID-19 progression to severe pneumonia, animal study shows

A team of scientists at the National Institute of Allergy and Infectious Diseases, which is part of the U.S. National Institutes of Health, has tested the efficacy of remdesivir, a nucleotide analog prodrug with a broad antiviral activity, as a COVID-19 treatment.

Source link

Related posts

Patients push limits for clues to chronic fatigue syndrome


Opinion: What roulette and basketball can teach Biogen about aducanumab


Das Engagement von Pampers für UNICEF erreicht weiteren Meilenstein im Kampf gegen Tetanus bei Müttern und Neugeborenen


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World